During follow-up, subsequent cancers were more frequently diagnosed in BRCA patients (19.0% in BRCA1 vs. 21.0% in BRCA2 vs. 5.9% in BRCA-wt, p = 0.002). The gene discussed is BRCA2; the disease is cancer.